Literature DB >> 1323602

Hepatic expression of type A and type B receptors for tumor necrosis factor.

R Volpes1, J J van den Oord, R De Vos, V J Desmet.   

Abstract

We have examined the in-situ distribution of type A and type B receptors for tumor necrosis factor (TNF) in normal and diseased human liver biopsy specimens. In normal liver tissue, no or very small amounts of TNF receptors were found. In acute and chronic inflammatory liver diseases, a strong up-regulation of the expression of both TNF receptors was found on hepatocytes, bile duct epithelium, sinusoidal lining cells and mononuclear inflammatory cells. With immunoelectronmicroscopy, all these cells showed cytoplasmic, in addition to membranous staining, suggesting active synthesis of the receptor or, alternatively, internalization of the receptor and its ligand. This up-regulated expression of both type A and type B receptors for TNF was similar in acute and chronic active hepatitis, and was not related to the etiology of the liver disease, nor restricted to areas of liver inflammation. Our results indicate that hepatocytes, sinusoidal endothelial cells, bile duct epithelial cells and mononuclear inflammatory cells, by displaying receptors for TNFs, represent target cells for both these cytokines. Up-regulated expression of type A and type B receptors for TNFs endows these cells with augmented responsiveness for the pleiomorphic biological activities of these cytokines during liver injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323602     DOI: 10.1016/0168-8278(92)90184-q

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Soluble tumor necrosis factor receptors in patients with recurrent hepatitis C virus infection after liver transplantation.

Authors:  J C Arnold; B Heilig; B Kallinowski; G Otto; B Kommerell; L Theilmann
Journal:  Clin Investig       Date:  1994-06

3.  High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice.

Authors:  Mayumi Yamato; Takeshi Shiba; Tomomi Ide; Naoko Seri; Wataru Kudo; Makoto Ando; Ken-ichi Yamada; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Mol Cell Biochem       Date:  2011-08-18       Impact factor: 3.396

4.  Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection.

Authors:  D R Nelson; H L Lim; C G Marousis; J W Fang; G L Davis; L Shen; M S Urdea; J A Kolberg; J Y Lau
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

5.  Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis.

Authors:  Abdel-Majid Khatib; Patrick Auguste; Lucia Fallavollita; Ni Wang; Amir Samani; Maria Kontogiannea; Sarkis Meterissian; Pnina Brodt
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

Review 6.  Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease.

Authors:  Ekta Pandey; Aiah S Nour; Edward N Harris
Journal:  Front Physiol       Date:  2020-07-21       Impact factor: 4.566

7.  Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.

Authors:  M J Hussain; J Y Lau; R Williams; D Vergani
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

8.  TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.

Authors:  X-F Zhang; R Zhang; L Huang; P-X Wang; Y Zhang; D-S Jiang; L-H Zhu; S Tian; X-D Zhang; H Li
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.